サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：免疫学の世界市場規模調査＆予測、疾患適応別薬物クラス別、流通チャネル別、地域別分析、2022-2029年
市場調査レポート
商品コード
1261226

免疫学の世界市場規模調査＆予測、疾患適応別薬物クラス別、流通チャネル別、地域別分析、2022-2029年

Global Immunology Market Size study & Forecast, by Drug Class by Disease Indication, by Distribution Channel and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫学の世界市場規模調査＆予測、疾患適応別薬物クラス別、流通チャネル別、地域別分析、2022-2029年
出版日: 2023年04月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の免疫学市場は、2021年に約979億3,000万米ドルと評価され、予測期間2022-2029年には8.5%以上の健全な成長率で成長すると予測されています。

免疫学は、免疫系に焦点を当て、研究する医学・生物学の研究分野です。免疫システムは、多くの方法で個人を感染から守っています。免疫システムを強化または阻害することで、免疫学的な反応を変化させるのが、免疫学の薬や物質です。免疫学の薬剤や物質は、感染症や、1型糖尿病、関節リウマチ、乾癬性関節炎などの自己免疫疾患や免疫学的疾患の治療や予防に使用されています。世界市場の成長は、バイオシミラーに対する需要の急増、免疫疾患に対する意識の高まり、予防医療に対する需要の増加といった要因によってもたらされます。

また、自己免疫疾患の発生件数の増加は、世界市場における市場需要を規定する重要な要因となっています。National Stem Cell Foundationの調査によると、80以上の自己免疫疾患のうち少なくとも1つは、世界中の約4％の人が罹患していると推定されています。例えば、患者の間でこれらの薬に対する需要が高まっていることから、様々な市場参入企業が新製品の創出と市場への導入に注力しています。例えば、Lupinは2020年9月に関節リウマチのジェネリック医薬品を発表しました。同様に、2022年4月現在、ジョンソン・エンド・ジョンソンサービス社からは、関節症性乾癬、関節リウマチ、炎症性腸疾患など、様々な自己免疫疾患適応のパイプラインプロジェクトが約20件、免疫分野ではサノフィ社のパイプラインプロジェクトが約30件あります。これにより、自己免疫疾患の有病率の上昇とその治療法の導入に重点を置くようになったことが、市場の成長を後押ししています。さらに、新規治療法の導入が進み、規制当局による製品承認が増加していることも、予測される数年間にさまざまな有利な機会をもたらしています。しかし、治療費の高さや製品に関連する副作用が、2022-2029年の予測期間を通じて市場成長の妨げとなっています。

世界の免疫学市場の調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、高度なヘルスケアインフラが整っていることに加え、研究開発への投資が拡大していることから、売上高で市場を独占しています。一方、アジア太平洋地域は、自己免疫疾患の増加、予防医療への需要の高まり、医薬品認可の増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 免疫学市場、地域別、2019-2029年
    • 免疫学市場、薬物クラス別、2019-2029年
    • 免疫学市場、疾患適応症別、2019-2029年
    • 免疫学市場、流通チャネル別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 免疫学の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 免疫学の世界市場力学

  • 免疫学市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 自己免疫疾患の増加
      • バイオシミラーに対する需要の急増
    • 市場の課題
      • 高額な治療費
      • 製品に関連する有害事象
    • 市場機会
      • 革新的な製品のイントロダクションの増加
      • 規制当局別製品認可の増加

第4章 世界の免疫学市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 免疫学の世界市場：薬物クラス別

  • マーケットスナップショット
  • 免疫学の世界市場：薬物クラス別、実績 - ポテンシャル分析
  • 免疫学の世界市場薬剤クラス別推定・予測2019-2029
  • 免疫学市場、サブセグメント別分析
    • モノクローナル抗体
    • 免疫抑制剤（Immunosuppressants
    • 融合蛋白質
    • その他

第7章 免疫学の世界市場：疾患適応症別

  • マーケットスナップショット
  • 免疫学の世界市場：適応疾患別、実績 - ポテンシャル分析
  • 免疫学の世界市場疾患別推定・予測2019-2029
  • 免疫学市場、サブセグメント別分析
    • 関節リューマチ
    • 乾癬性関節炎（Psoriatic Arthritis
    • プラーク乾癬（Psoriasis
    • 強直性脊椎炎（Ankylosing Spondylitis
    • 炎症性腸疾患（Inflammatory Bowel Disease
    • その他

第8章 免疫学の世界市場：流通チャネル別

  • マーケットスナップショット
  • 免疫学の世界市場：流通チャネル別、実績 - ポテンシャル分析
  • 免疫学の世界市場流通チャネル別推定・予測2019-2029
  • 免疫学市場、サブセグメント別分析
    • 病院内薬局
    • 小売薬局
    • オンラインファーマシーズ

第9章 免疫学の世界市場：地域別分析

  • 免疫学市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬剤クラス別の推定・予測、2019年～2029年
      • 疾患別適応症別の推定・予測、2019-2029年
      • 流通チャネル別の推定・予測、2019年～2029年
    • カナダ
  • 欧州免疫学市場のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の免疫学市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの免疫学市場のスナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • AbbVie, Inc.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Janssen Global Services, LLC
    • Eli Lilly and Company
    • Novartis AG
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Merck Sharp & Dohme Corp.
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Astellas Pharma Inc.

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Immunology Market, report scope
  • TABLE 2. Global Immunology Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Immunology Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Immunology Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Immunology Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Immunology Market
  • TABLE 71. List of primary sources, used in the study of global Immunology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Immunology Market, research methodology
  • FIG 2. Global Immunology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Immunology Market, key trends 2021
  • FIG 5. Global Immunology Market, growth prospects 2022-2029
  • FIG 6. Global Immunology Market, porters 5 force model
  • FIG 7. Global Immunology Market, pest analysis
  • FIG 8. Global Immunology Market, value chain analysis
  • FIG 9. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Immunology Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Immunology Market, regional snapshot 2019 & 2029
  • FIG 15. North America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Immunology Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Immunology Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Immunology Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Immunology Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Immunology is the field of medical and biological research that focuses and studies the immune system. The immune system protects individuals from infection in numerous ways. by enhancing or inhibiting the immune system, immunology medications and substances alter the immunological response. Immunology drugs or agents are used to treat or prevent infections as well as several autoimmune and immunological diseases such type 1 diabetes, rheumatoid arthritis, and psoriatic arthritis. The global market growth is primarily driven by the factors such as a surge in demand for biosimilars, growing awareness about immunological diseases, coupled with the increasing demand for preventive care.

In addition, the rise in incidences of autoimmune disorders is a key factor that is stipulating the market demand in the global market. A study by the National Stem Cell Foundation estimates that at least one of 80 or more autoimmune illnesses affects about 4% of people around the world. For instance, various market participants are focusing on creating and introducing new products to the market as a result of the growing demand for these medications among patients. For instance, Lupin introduced a generic rheumatoid arthritis medication in September 2020. Likewise, As of April 2022, there were approximately 20 pipeline projects from Johnson & Johnson Services, Inc. for a variety of autoimmune indications, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and others, and approximately 30 pipeline projects from Sanofi in the immunology segment. Thereby, the increasing prevalence of autoimmune disorders and growing emphasis on introducing its treatments is boosting the market growth. Moreover, the rising introduction of novel therapies, as well as the increasing product approvals by regulatory agencies are presenting various lucrative opportunities over the forecasting years. However, the high cost of treatment and adverse effects associated with the product are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Immunology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced healthcare infrastructure, along with growing investment on research and development activities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising occurrence of autoimmune conditions, surging demand for preventive care, and increasing drug approvals in the regional market space.

Major market players included in this report are:

  • AbbVie, Inc.
  • Janssen Global Services, LLC
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Merck Sharp & Dohme Corp.
  • F. Hoffmann-La Roche Ltd.
  • Amgen Inc.
  • Astellas Pharma Inc.

Recent Developments in the Market:

  • In June 2022, Eli Lilly and Company received the U.S. FDA approval for its OLUMIANT- a first-in-disease systemic treatment that is specially developed for adults with severe alopecia areata (AA), an autoimmune disorder.
  • In April 2022, AbbVie Inc. received the U.S. FDA approval for its RINVOQ to provide treatment to adult patients with active ankylosing spondylitis.
  • In March 2022, Pfizer Inc. announced that the company acquired Arena Pharmaceuticals, a company that primarily focuses on advancing innovative potential therapies to cure several immuno-inflammatory diseases. The objective of this acquisition is to expand Pfizer Inc. product portfolio.

Global Immunology Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Disease Indication, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Monoclonal Antibody
  • Immunosuppressants
  • Fusion Proteins
  • Others

By Disease Indication:

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
  • Inflammatory Bowel Disease
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Immunology Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Immunology Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Immunology Market, by Disease Indication, 2019-2029 (USD Billion)
    • 1.2.4. Immunology Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Immunology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Immunology Market Dynamics

  • 3.1. Immunology Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of autoimmune disorders
      • 3.1.1.2. Surge in demand for biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment
      • 3.1.2.2. Adverse effects associated with product
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Introduction of innovative products
      • 3.1.3.2. Increasing product approvals by regulatory agencies

Chapter 4. Global Immunology Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Immunology Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Immunology Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Immunology Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Immunology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibody
    • 6.4.2. Immunosuppressants
    • 6.4.3. Fusion Proteins
    • 6.4.4. Others

Chapter 7. Global Immunology Market, by Disease Indication

  • 7.1. Market Snapshot
  • 7.2. Global Immunology Market by Disease Indication, Performance - Potential Analysis
  • 7.3. Global Immunology Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
  • 7.4. Immunology Market, Sub Segment Analysis
    • 7.4.1. Rheumatoid Arthritis
    • 7.4.2. Psoriatic Arthritis
    • 7.4.3. Plaque Psoriasis
    • 7.4.4. Ankylosing Spondylitis
    • 7.4.5. Inflammatory Bowel Disease
    • 7.4.6. Others

Chapter 8. Global Immunology Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Immunology Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Immunology Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Immunology Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Immunology Market, Regional Analysis

  • 9.1. Immunology Market, Regional Market Snapshot
  • 9.2. North America Immunology Market
    • 9.2.1. U.S. Immunology Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Immunology Market
  • 9.3. Europe Immunology Market Snapshot
    • 9.3.1. U.K. Immunology Market
    • 9.3.2. Germany Immunology Market
    • 9.3.3. France Immunology Market
    • 9.3.4. Spain Immunology Market
    • 9.3.5. Italy Immunology Market
    • 9.3.6. Rest of Europe Immunology Market
  • 9.4. Asia-Pacific Immunology Market Snapshot
    • 9.4.1. China Immunology Market
    • 9.4.2. India Immunology Market
    • 9.4.3. Japan Immunology Market
    • 9.4.4. Australia Immunology Market
    • 9.4.5. South Korea Immunology Market
    • 9.4.6. Rest of Asia Pacific Immunology Market
  • 9.5. Latin America Immunology Market Snapshot
    • 9.5.1. Brazil Immunology Market
    • 9.5.2. Mexico Immunology Market
    • 9.5.3. Rest of Latin America Immunology Market
  • 9.6. Rest of The World Immunology Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Janssen Global Services, LLC
    • 10.2.3. Eli Lilly and Company
    • 10.2.4. Novartis AG
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Bristol-Myers Squibb Company
    • 10.2.7. Merck Sharp & Dohme Corp.
    • 10.2.8. F. Hoffmann-La Roche Ltd.
    • 10.2.9. Amgen Inc.
    • 10.2.10. Astellas Pharma Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption